Lannett Company Inc. recalls Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philade…
- Recall date
- August 11, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0599-2025
- FDA classification
- Class II
- Brand / firm
- Lannett Company Inc.
- Sold / distributed
- Nationwide within the USA
Why it was recalled
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
Get recall alerts
Free email alert whenever Lannett Company Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Lannett Company Inc.